MDxHealth SA
MDXH3.530USD
+0.130+3.82%
Fechamento 02/06, 16:00（ET）Cotações atrasadas em 15 min
174.73MValor de mercado
PerdaP/L TTM
Mais detalhes de MDxHealth SA Empresa
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
Informações de MDxHealth SA
Código da empresaMDXH
Nome da EmpresaMDxHealth SA
Data de listagemJun 26, 2006
CEOMr. Michael K. McGarrity
Número de funcionários312
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 26
EndereçoCAP Business Center
CidadeHERSTAL
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísBelgium
Código postal4040
Telefone3243642070
Sitehttps://mdxhealth.com/
Código da empresaMDXH
Data de listagemJun 26, 2006
CEOMr. Michael K. McGarrity
Executivos da empresa MDxHealth SA
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael K. McGarrity
Mr. Michael K. McGarrity
Chief Executive Officer, Director
Chief Executive Officer, Director
95.00K
--
Mr. Michael Holder
Mr. Michael Holder
Director
Director
--
--
Mr. Mark Shaffar
Mr. Mark Shaffar
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Christopher (Chris) Thibodeau
Mr. Christopher (Chris) Thibodeau
Executive Vice President & U.S. Chief Operations Officer
Executive Vice President & U.S. Chief Operations Officer
--
--
Dr. Sanford S Siegel, M.D.
Dr. Sanford S Siegel, M.D.
Director
Director
--
--
Mr. Joseph (Joe) Sollee
Mr. Joseph (Joe) Sollee
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Mr. John Bellano
Mr. John Bellano
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Rudi Marien
Mr. Rudi Marien
Non-Executive Director
Non-Executive Director
--
--
Mme. Ruth Devenyns
Mme. Ruth Devenyns
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Walter M. (Wally) Narajowski
Mr. Walter M. (Wally) Narajowski
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael K. McGarrity
Mr. Michael K. McGarrity
Chief Executive Officer, Director
Chief Executive Officer, Director
95.00K
--
Mr. Michael Holder
Mr. Michael Holder
Director
Director
--
--
Mr. Mark Shaffar
Mr. Mark Shaffar
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Christopher (Chris) Thibodeau
Mr. Christopher (Chris) Thibodeau
Executive Vice President & U.S. Chief Operations Officer
Executive Vice President & U.S. Chief Operations Officer
--
--
Dr. Sanford S Siegel, M.D.
Dr. Sanford S Siegel, M.D.
Director
Director
--
--
Mr. Joseph (Joe) Sollee
Mr. Joseph (Joe) Sollee
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Detalhamento da receita
Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2023
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States of America
69.71M
99.31%
Europe
476.00K
0.68%
Rest of the world
9.00K
0.01%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: há 3 horas
Atualizado em: há 3 horas
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Bleichroeder LP
14.91%
AWM Investment Company, Inc.
10.55%
MVM Partners LLP
9.50%
Lytton (Laurence W)
6.36%
Genomic Health, Inc.
4.93%
Outro
53.75%
Investidores
Investidores
Proporção
Bleichroeder LP
14.91%
AWM Investment Company, Inc.
10.55%
MVM Partners LLP
9.50%
Lytton (Laurence W)
6.36%
Genomic Health, Inc.
4.93%
Outro
53.75%
Tipos de investidores
Investidores
Proporção
Investment Advisor
20.60%
Investment Advisor/Hedge Fund
14.94%
Venture Capital
9.52%
Individual Investor
6.67%
Corporation
4.93%
Hedge Fund
1.21%
Research Firm
0.12%
Outro
42.00%
Participação acionária institucional
Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
71
22.89M
46.25%
-1.34M
2025Q3
49
21.80M
44.04%
-2.18M
2025Q2
45
28.07M
56.71%
+2.44K
2025Q1
47
29.82M
60.25%
-710.83K
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Bleichroeder LP
7.38M
14.91%
--
--
Sep 30, 2025
AWM Investment Company, Inc.
5.22M
10.55%
--
--
Sep 30, 2025
MVM Partners LLP
4.70M
9.5%
--
--
Sep 30, 2025
Lytton (Laurence W)
3.15M
6.36%
-799.84K
-20.25%
Sep 30, 2025
Genomic Health, Inc.
2.44M
4.93%
+1.50M
+159.38%
Sep 27, 2024
Samjo Capital, LLC
1.45M
2.92%
-89.90K
-5.86%
Sep 30, 2025
Perkins Capital Management, Inc.
1.40M
2.83%
-17.42K
-1.23%
Sep 30, 2025
Kennedy Capital Management LLC
392.65K
0.79%
+344.85K
+721.41%
Sep 30, 2025
Northern Trust Global Investments Limited
305.07K
0.62%
-106.86K
-25.94%
Sep 30, 2025
FreeGulliver LLC
252.89K
0.51%
+129.35K
+104.70%
Sep 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares Micro-Cap ETF
0.04%
iShares Micro-Cap ETF
Proporção0.04%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
